Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2010 1
2014 1
2015 1
2016 1
2018 4
2019 8
2020 6
2021 5
2022 8
2023 9
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Secukinumab (AIN457) for the treatment of psoriasis.
López-Ferrer A, Vilarrasa E, Puig L. López-Ferrer A, et al. Among authors: vilarrasa e. Expert Rev Clin Immunol. 2015;11(11):1177-88. doi: 10.1586/1744666X.2015.1095092. Epub 2015 Oct 1. Expert Rev Clin Immunol. 2015. PMID: 26428036 Review.
The Essential Role of IL-17 as the Pathogenetic Link between Psoriasis and Metabolic-Associated Fatty Liver Disease.
Olveira A, Augustin S, Benlloch S, Ampuero J, Suárez-Pérez JA, Armesto S, Vilarrasa E, Belinchón-Romero I, Herranz P, Crespo J, Guimerá F, Gómez-Labrador L, Martín V, Carrascosa JM. Olveira A, et al. Among authors: vilarrasa e. Life (Basel). 2023 Feb 2;13(2):419. doi: 10.3390/life13020419. Life (Basel). 2023. PMID: 36836776 Free PMC article. Review.
New perspectives on the treatment of hidradenitis suppurativa.
Amat-Samaranch V, Agut-Busquet E, Vilarrasa E, Puig L. Amat-Samaranch V, et al. Among authors: vilarrasa e. Ther Adv Chronic Dis. 2021 Nov 23;12:20406223211055920. doi: 10.1177/20406223211055920. eCollection 2021. Ther Adv Chronic Dis. 2021. PMID: 34840709 Free PMC article. Review.
International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis.
van Huizen AM, Menting SP, Gyulai R, Iversen L, van der Kraaij GE, Middelkamp-Hup MA, Warren RB, Spuls PI; SPIN MTX Consensus Survey Study Group; Schejtman AA, Egeberg A, Firooz A, Kumar AS, Oakley A, Foulkes A, Ramos AMC, Fougerousse AC, Carija A, Akman-Karakas A, Horváth B, Fábos B, Matlock BH, Claréus BW, Castro C, Ferrándiz C, Correa CC, Marchesi C, Goujon C, Gonzalez C, Maldonado-García C, Hong CH, Griffiths CEM, Vestergaard C, Echeverría CM, de la Cruz C, Conrad C, Törocsik D, Drvar DL, Balak D, Jullien D, Appelen D, Kim DH, de Jong EMGJ, El Gamal E, Laffitte E, Mahé E, Sonkoly E, Colombo EP, Vilarrasa E, Willaert F, Novoa FD, Handjani F, Valenzuela F, Vílchez-Márquez F, Gonzalez GO, Krisztián G, Damiani G, Krnjevic-Pezic G, Pellerano G, Carretero G, Hunter HJA, Riad H, Oon HH, Boonen HPJ, Moussa IO, García-Doval I, Csányi I, Brajac I, Turchin I, Grozdev I, Weinberg JM, Nicolopoulos J, Wells J, Lambert JLW, Ingram JR, Prinz JC, de Souza Sittart JA, Sanchez JL, Hsiao JP, Castro-Ayarza JR, Maul JT, van den Reek JMPA, Trcko K, Barber K, Reich K, Gebauer KA, Khobzei K, Maul LV, Massari LP, Fardet L, le Cleach L, Misery L, Chandrashekar L, Muresanu LI, Lecluse L, Skov L, F… See abstract for full author list ➔ van Huizen AM, et al. Among authors: vilarrasa e. JAMA Dermatol. 2022 May 1;158(5):561-572. doi: 10.1001/jamadermatol.2022.0434. JAMA Dermatol. 2022. PMID: 35353175
External Validation of the IHS4-55 in a European Antibiotic-Treated Hidradenitis Suppurativa Cohort.
van Straalen KR, Tzellos T, Alavi A, Benhadou F, Cuenca-Barrales C, Daxhelet M, Daoud M, Efthymiou O, Giamarellos-Bourboulis EJ, Guillem P, Gulliver W, Jemec GBE, Katoulis A, Koenig A, Lazaridou E, Lowes MA, Marzano AV, Matusiak L, Molina-Leyva A, Moltrasio C, Pinter A, Potenza C, Prens EP, Romaní J, Saunte DM, Sayed C, Skroza N, Stergianou D, Szepietowski JC, Trigoni A, Vilarrasa E, Kyrgidis A, Zouboulis CC, van der Zee HH. van Straalen KR, et al. Among authors: vilarrasa e. Dermatology. 2023;239(3):362-367. doi: 10.1159/000528968. Epub 2023 Jan 30. Dermatology. 2023. PMID: 36630943 Free article.
Mohs micrographic surgery in dermatofibrosarcoma protuberans: Rate and risk factors for recurrence in a prospective cohort study from the Spanish Registry of Mohs Surgery (REGESMOHS) and review of the literature.
Nieto-Benito LM, Ciudad-Blanco C, Sanmartin-Jimenez O, Garces JR, Rodríguez-Prieto MA, Vilarrasa E, de Eusebio-Murillo E, Miñano-Medrano R, Escutia-Muñoz B, Gonzalez-Sixto B, Artola-Igarza JL, Alfaro Rubio A, Redondo P, Delgado-Jiménez Y, Sánchez-Schmidt JM, Allende-Markixana I, Alonso-Pacheco ML, García-Bracamonte B, de la Cueva Dobao P, Navarro-Tejedor R, Suarez-Fernández R, Carnero-González L, Vázquez-Veiga H, Barchino-Ortiz L, Ruiz-Salas V, Sánchez-Sambucety P, López-Estebaranz JL, Botella-Estrada R, Feal-Cortizas C, Martorell Calatayud A, Gil P, Morales-Gordillo V, Toll-Abelló A, Ocerin-Guerra I, Mayor-Arenal M, Garcia-Donoso C, Cano-Martinez N, Sainz-Gaspar L, Descalzo MA, Garcia-Doval I; REGESMOHS (Registro Español de Cirugía de Mohs). Nieto-Benito LM, et al. Among authors: vilarrasa e. Exp Dermatol. 2021 May;30(5):717-722. doi: 10.1111/exd.14291. Epub 2021 Feb 13. Exp Dermatol. 2021. PMID: 33523531 Review.
Response letter to "Tracing the origins of setons in hidradenitis suppurativa: A commentary to Vilarrasa et al's 'Drainage setons for the management of sinus tracts in hidradenitis suppurativa'".
Camiña-Conforto G, Vilarrasa E, Cabo F, Fernández-Vela J, Pousa M, Romaní J. Camiña-Conforto G, et al. Among authors: vilarrasa e. J Am Acad Dermatol. 2024 Apr;90(4):e141-e142. doi: 10.1016/j.jaad.2023.11.049. Epub 2023 Dec 5. J Am Acad Dermatol. 2024. PMID: 38056528 No abstract available.
Drug survival of adalimumab biosimilars in real-world treatment of psoriasis: A Spanish multicenter study.
López-Ferrer A, Vilarrasa E, Armesto S, Santos-Juanes J, Galache C, Carretero G, Sahuquillo A, Salgado-Boquete L, Del Alcázar E, González-Cantero A, Martorell A, Rivera-Díaz R, Mitxelena-Ezeiza J, Mateu A, Belinchón I, Llamas-Velasco M, Riera-Monroig J, Lázaro A, López-Estebaranz JL, Gich I, Puig L. López-Ferrer A, et al. Among authors: vilarrasa e. Dermatol Ther. 2022 Nov;35(11):e15831. doi: 10.1111/dth.15831. Epub 2022 Sep 27. Dermatol Ther. 2022. PMID: 36109488 No abstract available.
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study.
Torres T, Chiricozzi A, Puig L, Lé AM, Marzano AV, Dapavo P, Dauden E, Carrascosa JM, Lazaridou E, Duarte G, Carvalho AVE, Romiti R, Rompoti N, Teixeira L, Abreu M, Ippoliti E, Maronese CA, Llamas-Velasco M, Vilarrasa E, Del Alcázar E, Daponte AI, Papoutsaki M, Carugno A, Bellinato F, Gisondi P. Torres T, et al. Among authors: vilarrasa e. Am J Clin Dermatol. 2024 Mar;25(2):333-342. doi: 10.1007/s40257-024-00845-4. Epub 2024 Jan 24. Am J Clin Dermatol. 2024. PMID: 38265746 Free PMC article.
39 results